Some people notice fewer hunger cues, earlier fullness, or less preoccupation with food
Members frequently note a decrease in alcohol desire and enjoyment while on GLP-1 medications
For background, see the FDA Federal Register determination on Geref (sermorelin acetate)
Psychiatry 66 , e99 (2023)
Ozempic is a GLP-1 receptor agonist that increases insulin secretion, decreases glucagon production, and slows down digestion, collectively working to lower blood sugar levels
Gonzlez Olmo BM, Butler MJ, Barrientos RM (2021) Evolution of the Human Diet and its impact on Gut Microbiota, Immune responses, and Brain Health